Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TXMD |
---|---|---|
09:32 ET | 414 | 1.46 |
09:33 ET | 1100 | 1.45 |
09:35 ET | 915 | 1.45 |
09:51 ET | 100 | 1.4835 |
10:02 ET | 339 | 1.47 |
10:08 ET | 100 | 1.47 |
10:15 ET | 100 | 1.4543 |
10:18 ET | 290 | 1.45 |
10:31 ET | 100 | 1.45 |
10:47 ET | 600 | 1.4499 |
11:02 ET | 2948 | 1.45 |
11:25 ET | 154 | 1.45 |
12:01 ET | 103 | 1.45 |
12:03 ET | 611 | 1.43 |
12:08 ET | 100 | 1.43 |
12:33 ET | 278 | 1.42 |
12:35 ET | 3730 | 1.42 |
12:48 ET | 1192 | 1.4 |
01:11 ET | 866 | 1.4 |
01:15 ET | 2300 | 1.41 |
01:45 ET | 180 | 1.42 |
01:51 ET | 500 | 1.4195 |
01:54 ET | 171 | 1.4199 |
02:05 ET | 1000 | 1.425 |
02:07 ET | 1305 | 1.4 |
02:38 ET | 100 | 1.38 |
02:43 ET | 284 | 1.38 |
03:24 ET | 1009 | 1.38 |
03:37 ET | 358 | 1.36 |
03:44 ET | 542 | 1.39 |
03:48 ET | 100 | 1.4091 |
04:00 ET | 239 | 1.4 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TherapeuticsMD Inc | 16.1M | -4.0x | --- |
Talphera Inc | 11.7M | -1.0x | --- |
BioQuest Corp | 10.9M | -19.6x | --- |
Allied Corp | 5.5M | -0.7x | --- |
SYBLEU Inc | 5.5M | -1.9x | --- |
Sentient Brands Holdings Inc | 5.4M | -5.1x | --- |
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.1M |
---|---|
Revenue (TTM) | $1.6M |
Shares Outstanding | 11.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.14 |
EPS | $-0.35 |
Book Value | $2.54 |
P/E Ratio | -4.0x |
Price/Sales (TTM) | 10.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -379.20% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.